TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1674825

Group type: COMPARATOR
Intervention: Cetirizine 10 mg orally twice daily for one week
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cetirizine 5 mg/ml inhaled
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cetirizine 10 mg/ml inhaled
Number of subjects: 20
Study: 6170218

Group type: EXPERIMENTAL
Intervention: Ground white rice
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Ground brown rice
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: White rice
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 4
Study: 30668423

Group type: EXPERIMENTAL
Intervention: Extract mixture of Andrographis paniculata and Syzygium polyanthum at a dose of 900 mg/day for 8 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 54
Study: 28837015

Group type: EXPERIMENTAL
Intervention: Community paramedicine services for 12 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 200
Study: 26790200

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (Baihui, Sishencong, Shenting, Yintang, Hegu, Taichong) applied in the observation group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cognitive rehabilitation training in the control group
Number of subjects: 100
Study: 23125396

Group type: EXPERIMENTAL
Intervention: CR+MRIGE
Number of subjects: 59

Group type: COMPARATOR
Intervention: CR
Number of subjects: 59
Study: 21288450

Group type: EXPERIMENTAL
Intervention: Chinese herbal decoctions for warming meridians to nourish blood and cervical traction (treatment group)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Cervical traction (control group)
Number of subjects: 63
Study: 19321576

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient-fortified biscuits (including iron 6 mg, zinc 5.6 mg, iodine 35 microg, vitamin A 300 microg retinol equivalents) given 5 days/week for 4 months
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient-fortified biscuits
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Multi-micronutrient-fortified biscuits with Albendazole (400 mg)
Number of subjects: 510
Study: 16213292

Group type: EXPERIMENTAL
Intervention: Single daily dose of cyclosporine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Twice daily dosing of cyclosporine (control group)
Number of subjects: 15
Study: 11826593

Group type: EXPERIMENTAL
Intervention: SF6 echocontrast agent (SonoVue) 0.3 mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SF6 echocontrast agent (SonoVue) 0.6 mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SF6 echocontrast agent (SonoVue) 1.2 mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: SF6 echocontrast agent (SonoVue) 2.4 mL
Number of subjects: 30
Study: 10084096

Group type: EXPERIMENTAL
Intervention: 16 mg min‐1 propofol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 25 mg min‐1 propofol
Number of subjects: 40
Study: 7725880

Group type: EXPERIMENTAL
Intervention: Halothane-diethyl-ether azeotrope (HE)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isoflurane (ISO)
Number of subjects: 12
Study: 1706012

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 240 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 300 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem 360 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7455480

Group type: EXPERIMENTAL
Intervention: Iron supplementation in female blood donors
Number of subjects: 171

Group type: COMPARATOR
Intervention: No iron supplementation in male blood donors
Number of subjects: 171
Study: 30450721

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Artificial tears of sodium hyaluronate (SH)
Number of subjects: 83
Study: 28590309

Group type: EXPERIMENTAL
Intervention: Deflated airway (G1)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Pre-inflated cuff (G2)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Pre-inflated cuff with external lifting of the larynx (G3)
Number of subjects: 441

Group type: COMPARATOR
Intervention: Deflated airway (G1) and Pre-inflated cuff (G2) combined
Number of subjects: 441
Study: 26044067

Group type: EXPERIMENTAL
Intervention: Efavirenz 400 mg (EFV400)
Number of subjects: 606

Group type: COMPARATOR
Intervention: Efavirenz 600 mg (EFV600)
Number of subjects: 606
Study: 24124717

Group type: EXPERIMENTAL
Intervention: Sevoflurane and propofol anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol and remifentanil anesthesia
Number of subjects: 60
Study: 21256786

Group type: COMPARATOR
Intervention: Standard oral hygiene with chlorhexidine (GS)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Standard oral hygiene with electric dental brush (GR)
Number of subjects: 147
Study: 19616720

Group type: EXPERIMENTAL
Intervention: Immediate circumcision (n=474)
Number of subjects: 922

Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months (n=448)
Number of subjects: 922

Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 922

Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months
Number of subjects: 922
Study: 17667888

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 500 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 15364766

Group type: EXPERIMENTAL
Intervention: PSV plus PEEP (various settings)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High levels of assistance
Number of subjects: 36

Group type: COMPARATOR
Intervention: PSV plus PEEP
Number of subjects: 36
Study: 11596685

Group type: EXPERIMENTAL
Intervention: Interactive, multimedia CD‐ROM program
Number of subjects: 42

Group type: COMPARATOR
Intervention: Traditional lecture with black and white overhead transparencies and an 18‐minute videotape
Number of subjects: 42
Study: 9482351

Group type: EXPERIMENTAL
Intervention: Sidestream tobacco smoke (SS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 23
Study: 8076657

Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor), initiated within 24 hours from the onset of the infarct and continued for 6 months
Number of subjects: 6090

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6090
Study: 2915238

Group type: EXPERIMENTAL
Intervention: One-day cisplatin, doxorubicin, and cyclophosphamide (PAC-I) chemotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Five-day PAC (PAC-V) chemotherapy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Optimal stage III disease
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Suboptimal or stage IV disease
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patients with ascites at diagnosis
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patients without ascites at diagnosis
Number of subjects: 56
Study: 1228414

Group type: EXPERIMENTAL
Intervention: Plastic cannula, catheter changed every 48 hr
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plastic cannula, catheter changed only when necessary
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Metal needle, catheter changed every 48 hr
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metal needle, catheter changed only when necessary
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Catheters in place for longer than 56 hr
Number of subjects: 50

Group type: COMPARATOR
Intervention: Catheters in place for less than 56 hr
Number of subjects: 50
Study: 31340252

Group type: EXPERIMENTAL
Intervention: Hospital Survey on Patient Safety Culture (HSOPS)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Previous year event reporting
Number of subjects: 314
Study: 27696678

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation for 15 minutes daily for 90 days
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal routine (control group)
Number of subjects: 37
Study: 26656017

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioural therapy (CBT) for CSOs, delivered over 10 weeks with nine modules and therapist support via email and telephone.
Number of subjects: 150
Study: 23302419

Group type: EXPERIMENTAL
Intervention: Standard goniometry
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diagrammatic goniometry (paper goniometer)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both goniometers (standard and paper)
Number of subjects: 24
Study: 21808851

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg, 3 times/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18296970

Group type: COMPARATOR
Intervention: Heavy Back Squats (HBS)
Number of subjects: 10
Study: 15803287

Group type: EXPERIMENTAL
Intervention: Combined mitoxantrone and methylprednisolone therapy
Number of subjects: 65
Study: 12242746

Group type: EXPERIMENTAL
Intervention: Male instructors
Number of subjects: 44

Group type: COMPARATOR
Intervention: Female instructors
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both male and female instructors
Number of subjects: 44
Study: 9824924

Group type: EXPERIMENTAL
Intervention: PTSD checklist (PCL-C)
Number of subjects: 65
Study: 7549222

Group type: EXPERIMENTAL
Intervention: Zatebradine (10 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2686485

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 20
Study: 31960497

Group type: EXPERIMENTAL
Intervention: High-fecundity group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-fecundity group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DEmRNAs SRD5A2, LOC102191297, LOC102171967
Number of subjects: 0
Study: 30037019

Group type: EXPERIMENTAL
Intervention: Coconut oil (CoG, n = 18)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Chia oil (ChG, n = 19)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Safflower oil (SafG, n = 19)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Soybean oil placebo (PG, n = 19)
Number of subjects: 75
Study: 25641255

Group type: EXPERIMENTAL
Intervention: MBG-0/1
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: MBG-0/1 with normal post-PCI epicardial TIMI-3 flow
Number of subjects: 3115

Group type: COMPARATOR
Intervention: Normal myocardial perfusion
Number of subjects: 3115
Study: 24607500

Group type: EXPERIMENTAL
Intervention: Community-based CBT-I workshops
Number of subjects: 151

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 151
Study: 21921071

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg daily for 6 months)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 20112246

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 57

Group type: COMPARATOR
Intervention: School Counseling (SC)
Number of subjects: 57
Study: 18506741

Group type: EXPERIMENTAL
Intervention: Ultra-fast chromatographic micro-assay for DPN quantification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formulations of DPN
Number of subjects: 0
Study: 15816586

Group type: COMPARATOR
Intervention: Postoperative music
Number of subjects: 75

Group type: COMPARATOR
Intervention: Intraoperative music
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Silence (control group)
Number of subjects: 75
Study: 11199956

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 9714526

Group type: EXPERIMENTAL
Intervention: Oral pamidronate 300 mg daily
Number of subjects: 16
Study: 7974586

Group type: EXPERIMENTAL
Intervention: ECST method
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: CC method
Number of subjects: 1001

Group type: COMPARATOR
Intervention: NASCET method
Number of subjects: 1001
Study: 2662982

Group type: EXPERIMENTAL
Intervention: Electronic fetal monitoring (EFM) using continuous Doppler and tocodynamometer when membranes intact, and internal fetal scalp electrode and pressure catheter once membranes ruptured.
Number of subjects: 135

Group type: COMPARATOR
Intervention: Periodic monitoring with a DeLee fetoscope or amplified Doppler.
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Nursing support during labor.
Number of subjects: 135
Study: 29306223

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate intake
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (8-hour preoperative fasting)
Number of subjects: 152
Study: 25616519

Group type: EXPERIMENTAL
Intervention: High-protein diet (4 g/kg/d)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard-protein diet
Number of subjects: 25
Study: 24436758

Group type: EXPERIMENTAL
Intervention: Strut plate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Champy miniplate
Number of subjects: 13
Study: 21851202

Group type: EXPERIMENTAL
Intervention: TAU + DRT + Mentorship for Addictions Problems to Enhance Engagement to Treatment (MAP‐Engage)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: TAU + MAP‐Engage
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 96
Study: 19469885

Group type: EXPERIMENTAL
Intervention: Magnesium carbonate/calcium carbonate (elemental Mg: 86 mg/elemental Ca 100 mg) administered as phosphate binder for 18 months
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Magnesium carbonate/calcium carbonate (elemental Mg: 86 mg/elemental Ca 100 mg)
Number of subjects: 7
Study: 17273633

Group type: EXPERIMENTAL
Intervention: Presence of a labor companion during childbirth
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Labor companion's support
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Health care providers' management
Number of subjects: 27
Study: 15521232

Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine (1 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study: 11679451

Group type: EXPERIMENTAL
Intervention: OGTT + F (75 g glucose + 7.5 g fructose)
Number of subjects: 5

Group type: COMPARATOR
Intervention: OGTT - F (75 g glucose only)
Number of subjects: 5
Study: 9765038

Group type: EXPERIMENTAL
Intervention: Cervical spine locking plate (CSLP) in two-level disc fusions
Number of subjects: 18

Group type: COMPARATOR
Intervention: No plate fixation (grafting without fixation)
Number of subjects: 18
Study: 7834919

Group type: EXPERIMENTAL
Intervention: Lactate-buffered hemofiltration (lactate concentration 34-44.5 mmol/l)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Type II bicarbonate-buffered fluid (bicarbonate concentration 39.7 mmol/l)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Type I bicarbonate-buffered fluid (bicarbonate concentration 31.4 mmol/l)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Type II bicarbonate fluid (bicarbonate concentration 39.7 mmol/l)
Number of subjects: 11
Study: 29544063

Group type: EXPERIMENTAL
Intervention: l-arginine supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo supplementation
Number of subjects: 20
Study: 27786346

Group type: EXPERIMENTAL
Intervention: High-intensity Aerobic Exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Low-intensity Balance/Flexibility
Number of subjects: 47
Study: 23804232

Group type: EXPERIMENTAL
Intervention: Recombinant thrombomodulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22951491

Group type: EXPERIMENTAL
Intervention: Knee and hip exercise (KHE) group, n = 28; performed a 4-week program including hip abductors, lateral rotators, and extensors strengthening exercises
Number of subjects: 54

Group type: COMPARATOR
Intervention: Knee exercise (KE) group, n = 26; performed a 4-week conventional knee-stretching and strengthening program
Number of subjects: 54
Study: 20444914

Group type: EXPERIMENTAL
Intervention: Ruboxistaurin mesylate (PKCbeta antagonist)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 19071992

Group type: EXPERIMENTAL
Intervention: Words read aloud with Remember instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Words read aloud with Forget instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Words read silently with Remember instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Words read silently with Forget instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All studied items (implicit speeded reading test)
Number of subjects: 0
Study: 16708408

Group type: EXPERIMENTAL
Intervention: Plantago ovata (2 sachets daily of 3.26 g for 20 days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Glycerin oil (control group)
Number of subjects: 98
Study: 12615633

Group type: EXPERIMENTAL
Intervention: Recruitment maneuvers during suctioning
Number of subjects: 9

Group type: COMPARATOR
Intervention: Disconnection from the ventilator
Number of subjects: 9

Group type: COMPARATOR
Intervention: Suctioning through the swivel adapter
Number of subjects: 9

Group type: COMPARATOR
Intervention: Suctioning with a closed system
Number of subjects: 9

Group type: COMPARATOR
Intervention: Suctioning with pressure-supported breaths
Number of subjects: 9

Group type: COMPARATOR
Intervention: Recruitment after disconnection
Number of subjects: 9

Group type: COMPARATOR
Intervention: Recruitment using the swivel adapter
Number of subjects: 9

Group type: COMPARATOR
Intervention: Recruitment with the closed system
Number of subjects: 9
Study: 10781391

Group type: COMPARATOR
Intervention: Sodium selenite (50 microg of Se daily for 28 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Selenomethionine (50 microg of Se daily for 28 days)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Both treatments (Sodium selenite and Selenomethionine)
Number of subjects: 45
Study: 8748408

Group type: EXPERIMENTAL
Intervention: Dextran 40-based preservation solution (Dex-PS)
Number of subjects: 174

Group type: COMPARATOR
Intervention: University of Wisconsin (UW) solution
Number of subjects: 174
Study: 1407917

Group type: EXPERIMENTAL
Intervention: 3 mg intravaginal PGE2 tablets
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo intravaginal tablets (Control)
Number of subjects: 18
Study: 2996161

Group type: EXPERIMENTAL
Intervention: Ampicillin and Sulbactam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clindamycin and Gentamicin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both combinations of antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pseudomonas isolated patients
Number of subjects: 0
Study: 31688579

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.1 mg/d) + 200 mg progesterone (12 d every 3 mo)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 30571235

Group type: EXPERIMENTAL
Intervention: Intensive antihypertensive treatment (target systolic blood pressure <120 mm Hg)
Number of subjects: 4733

Group type: COMPARATOR
Intervention: Standard antihypertensive treatment (target systolic blood pressure <140 mm Hg)
Number of subjects: 4733

Group type: EXPERIMENTAL
Intervention: Both treatment groups (intensive and standard)
Number of subjects: 4733
Study: 26707957

Group type: EXPERIMENTAL
Intervention: Isometric exercise program (4 sessions per week for 4 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Isotonic exercise program (4 sessions per week for 4 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Isometric exercise program
Number of subjects: 29

Group type: COMPARATOR
Intervention: Isotonic exercise program
Number of subjects: 29
Study: 24368552

Group type: EXPERIMENTAL
Intervention: Fish oil (3,000 mg × day(‐1) for 3 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 22747575

Group type: EXPERIMENTAL
Intervention: Ticagrelor alone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ticagrelor with enoxaparin
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Ticagrelor with UFH
Number of subjects: 58
Study: 20149950

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) sessions
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: General items subscale of CMCS
Number of subjects: 1613

Group type: EXPERIMENTAL
Intervention: CMCS scores during training phase
Number of subjects: 1613
Study: 17378784

Group type: EXPERIMENTAL
Intervention: Venous occlusion during injection of propofol (10 mg/ml, 0.5 ml over 30 s)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No venous occlusion during injection of propofol (10 mg/ml, 0.5 ml over 30 s)
Number of subjects: 75
Study: 16322410

Group type: EXPERIMENTAL
Intervention: Template-driven medical documentation system (T-System for Primary Care)
Number of subjects: 1339

Group type: COMPARATOR
Intervention: Undirected handwritten documentation
Number of subjects: 1339
Study: 11981680

Group type: EXPERIMENTAL
Intervention: Prophylactic nasal continuous positive airway pressure (nCPAP) for the first postoperative night
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 204
Study: 9860107

Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg b.i.d.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moclobemide 600 mg b.i.d.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moclobemide (both doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7614813

Group type: EXPERIMENTAL
Intervention: Glucose (75 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tap water
Number of subjects: 14
Study: 2173443

Group type: EXPERIMENTAL
Intervention: 2‐chloroprocaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: lidocaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: butorphanol 2 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: fentanyl 50 micrograms
Number of subjects: 60

Group type: COMPARATOR
Intervention: butorphanol
Number of subjects: 60

Group type: COMPARATOR
Intervention: fentanyl
Number of subjects: 60
Study: 26099

Group type: EXPERIMENTAL
Intervention: Dipotassium chlorazepate 20 mg at bedtime
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dipotassium chlorazepate divided daily dose (5 + 5 + 10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31638282

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 28